BSX in the 13F filings
Boston Scientific Corp · CUSIP 101137107
- Quarter end
- 31 Mar 2025
- the date the book describes
- Filed
- 5 Nov 2026
- latest of these filings; the earliest 2 May 2025
- Managers listing it
- 44
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q4 2024 and Q1 2025; 40 listed it in both
- Shares listed
- 328,980,437
- combined, among listed positions
- Reported value
- $33.1bn
- combined, at the quarter end
1 line marked †. Value as filed implies a price far from other filers'. Each counts in holders and value as filed, and is left out of the net change in shares.
Among the 95 comparable managers: 22 buyers (opened or added shares) and 21 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing BSX in Q1 2025
44 of 44 holders
Largest increases and reductions, by shares
Increases
- Two Sigma Advisers LPexisting position · 4,205,960 shares now+3,450,700
- D. E. Shaw & Co.existing position · 3,839,144 shares now+3,075,641
- Two Sigma Investments LPexisting position · 2,440,747 shares now+1,698,900
- T. Rowe Price Associates Incexisting position · 10,610,487 shares now+1,664,108
- Capital Research Global Investorsexisting position · 5,943,966 shares now+1,648,607
Reductions
- Fidelity (FMR LLC)existing position · 128,597,214 shares now-3,845,669
- MFS Investment Managementexisting position · 16,521,619 shares now-3,138,336
- Wellington Management Group LLPexisting position · 33,197,842 shares now-2,967,557
- Artisan Partners LPexisting position · 9,659,288 shares now-1,572,974
- Farallon Capital Management LLCexisting position · 3,762,757 shares now-1,260,200
New positions and exits
New (2)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 13 | $3.9bn | n.a. | n.a. |
| Q3 2013 | 17 | $5.3bn | n.a. | n.a. |
| Q4 2013 | 15 | $4.8bn | n.a. | n.a. |
| Q1 2014 | 12 | $5.6bn | n.a. | n.a. |
| Q2 2014 | 15 | $5.1bn | n.a. | n.a. |
| Q3 2014 | 21 | $5.1bn | n.a. | n.a. |
| Q4 2014 | 16 | $5.3bn | n.a. | n.a. |
| Q1 2015 | 18 | $6.7bn | n.a. | n.a. |
| Q2 2015 | 19 | $6.9bn | n.a. | n.a. |
| Q3 2015 | 19 | $6.8bn | n.a. | n.a. |
| Q4 2015 | 20 | $7.4bn | n.a. | n.a. |
| Q1 2016 | 17 | $8.3bn | n.a. | n.a. |
| Q2 2016 | 24 | $10.6bn | n.a. | n.a. |
| Q3 2016 | 26 | $10.4bn | n.a. | n.a. |
| Q4 2016 | 25 | $9.2bn | n.a. | n.a. |
| Q1 2017 | 23 | $11.1bn | n.a. | n.a. |
| Q2 2017 | 26 | $12.7bn | n.a. | n.a. |
| Q3 2017 | 24 | $13.4bn | n.a. | n.a. |
| Q4 2017 | 30 | $11.5bn | n.a. | n.a. |
| Q1 2018 | 32 | $12.4bn | n.a. | n.a. |
| Q2 2018 | 25 | $15.3bn | n.a. | n.a. |
| Q3 2018 | 28 | $17.9bn | n.a. | n.a. |
| Q4 2018 | 28 | $16.2bn | n.a. | n.a. |
| Q1 2019 | 31 | $16.9bn | n.a. | n.a. |
| Q2 2019 | 23 | $19.2bn | n.a. | n.a. |
| Q3 2019 | 23 | $18.2bn | n.a. | n.a. |
| Q4 2019 | 26 | $19.7bn | n.a. | n.a. |
| Q1 2020 | 31 | $13.5bn | n.a. | n.a. |
| Q2 2020 | 29 | $14.1bn | n.a. | n.a. |
| Q3 2020 | 31 | $15.0bn | n.a. | n.a. |
| Q4 2020 | 35 | $13.6bn | n.a. | n.a. |
| Q1 2021 | 29 | $15.7bn | n.a. | n.a. |
| Q2 2021 | 27 | $18.2bn | n.a. | n.a. |
| Q3 2021 | 27 | $18.2bn | n.a. | n.a. |
| Q4 2021 | 26 | $17.4bn | n.a. | n.a. |
| Q1 2022 | 32 | $17.4bn | n.a. | n.a. |
| Q2 2022 | 30 | $14.0bn | n.a. | n.a. |
| Q3 2022 | 29 | $14.5bn | n.a. | n.a. |
| Q4 2022 | 26 | $16.6bn | n.a. | n.a. |
| Q1 2023 | 32 | $18.5bn | n.a. | n.a. |
| Q2 2023 | 37 | $19.6bn | n.a. | n.a. |
| Q3 2023 | 33 | $19.7bn | n.a. | n.a. |
| Q4 2023 | 30 | $20.6bn | 14 | 19 |
| Q1 2024 | 33 | $24.0bn | 13 | 19 |
| Q2 2024 | 35 | $26.8bn | 21 | 15 |
| Q3 2024 | 40 | $28.3bn | 25 | 15 |
| Q4 2024 | 40 | $29.4bn | 18 | 21 |
| Q1 2025 | 44 | $33.1bn | 22 | 21 |
| Q2 2025 | 44 | $33.6bn | 24 | 21 |
| Q3 2025 | 48 | $29.5bn | 29 | 19 |
| Q4 2025 | 49 | $28.5bn | 28 | 22 |
| Q1 2026 | 45 | $17.2bn | 23 | 27 |
| Q2 2026 | 40 | $13.0bn | 30 | 21 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
BSX and LLY →BSX and JNJ →BSX and VRTX →Choose a stock to compare with BSX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own BSX, latest filings →Back to the 13F Explorer →